Although MCL-1 plays a role in normal physiological processes, including cardiac and hepatic tissues, overexpression of MCL-1 and increased oncogenic addiction of tumor cells has emerged as a common determinant of venetoclax resistance100. Here, MCL1 is linked to neoplasm.